# SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid10872533
Categories: beauty, industrial, pharma
Identifier: DTXSID10872533

> SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE. EPA CPDat observed this chemical in 15 composition records across product categories including Laboratory supplies, Personal care, Medical/dental. Assessed from 51 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 15 composition records across product categories including Laboratory supplies, Personal care, Medical/dental.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 15 composition records across product categories including Laboratory supplies, Personal care, Medical/dental.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: 0.3 %w/w
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.5 %w/w
- US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 0.56 %w/w
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: INTRABURSAL; Dosage form: INJECTION; Potency: ADJ PH
- US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 200 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 80 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 279.27 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Potency: 0.34 %w/v
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 200 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 80 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 279.27 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 43 mg
- US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: INJECTION; Potency: 1.33 %w/v
- US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 5 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 2.15 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.48 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.48 %w/w
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 500 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 120 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 200 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 131 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 80 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.22 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 16.24 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 70 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 105 mg
- US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 0.38 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 3.2 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 3.43 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: 0.38 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 29 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Potency: 1.59 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: 0.15 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 49.78 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SPONGE; Potency: 0.9 %w/w
- US: inactive ingredient database — Route: VAGINAL; Dosage form: DOUCHE; Potency: 0.15 %w/w
- US: marketed drug occurrence — FDA NDC lists this ingredient in 137 active drug products and 141 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._